Janus Henderson Group’s Centessa Pharmaceuticals CNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $85.8M | Buy |
6,532,768
+610,282
| +10% | +$8.02M | 0.04% | 292 |
|
|
2025
Q1 | $86.4M | Buy |
5,922,486
+1,012,999
| +21% | +$14.8M | 0.05% | 283 |
|
|
2024
Q4 | $82.2M | Buy |
4,909,487
+3,614,623
| +279% | +$60.5M | 0.04% | 298 |
|
|
2024
Q3 | $20.7M | Buy |
+1,294,864
| New | +$20.7M | 0.01% | 571 |
|
|
2023
Q1 | – | Sell |
-2,114,519
| Closed | -$6.58M | – | 2692 |
|
|
2022
Q4 | $6.58M | Sell |
2,114,519
-3,775,393
| -64% | -$11.7M | ﹤0.01% | 806 |
|
|
2022
Q3 | $23.6M | Buy |
5,889,912
+2,461,392
| +72% | +$9.85M | 0.01% | 641 |
|
|
2022
Q2 | $16.7M | Sell |
3,428,520
-2,189,299
| -39% | -$10.7M | 0.01% | 597 |
|
|
2022
Q1 | $50.4M | Sell |
5,617,819
-125,578
| -2% | -$1.13M | 0.02% | 497 |
|
|
2021
Q4 | $63.1M | Buy |
5,743,397
+136,095
| +2% | +$1.5M | 0.03% | 478 |
|
|
2021
Q3 | $91.4M | Sell |
5,607,302
-73,631
| -1% | -$1.2M | 0.04% | 374 |
|
|
2021
Q2 | $120M | Buy |
+5,680,933
| New | +$120M | 0.05% | 337 |
|